Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2020 Sep 26;147(1):167–175. doi: 10.1007/s00432-020-03395-4

Fig. 3.

Fig. 3

Kaplan-Meier analysis of two-years overall survival (OS). (a). two-year OS (78.7%), (b). low vs high tumour canonical MET gene expression (80.0%vs 78.1%, P=0.88), (c). low vs high tumour L1-MET transcript expression (75.9% vs 83.3%, P=0.72), (d). low vs high tumour MET protein expression (76.0% vs 81.8%, P=0.84). No significant association was observed between MET and L1-MET transcripts, as well as, MET protein expressions and OS of HCC patients